Cowen & Co. analyst Vivien Azer upgrades Molson Coors Beverage (NYSE:TAP) from Market Perform to Outperform and raises the price target from $55 to $60.
Participants of the MLIV Pulse survey, who were asked which investor has the best tweets, have voted for "The Big Short" investor Michael Burry, who rose to prominence by betting a
Pfizer will now lead all development and commercialization activities in Mainland China, Hong Kong, Macau, and Singapore
LianBio will receive a $20 million upfront payment, to be released from previously